Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
The surgeons of tomorrow, along with anyone who might have been interested, were recently invited to experience the world's first live operation filmed in 360-degree VR.
Convincing patients to routinely check their blood-sugar is sometimes an uphill battle. In this video, Jane Seley, a certified diabetes educator (CDE) and diabetes nurse practitioner (DNP), shares…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Using a motor cortex implant, a series of electrode-lined bracelets, and sophisticated software, this paralyzed patient temporarily regained some use of his wrists and hands.
On April 8, 2016, the FDA updated labeling recommendations for metformin and metformin-containing drugs, expanding the indication(s) to include treatment for type 2 diabetes patients with mild-to-moderate renal…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
A new method of coaxing adult cells into iMS cells may be safer, more versatile, and more effective than current, experimental embryonic stem cell processes.
Neuroreader™ is an advanced piece of software that analyzes data from a patient’s structural MRI scan, measures 45 different brain structures (two-dozen more than any current competing software),…
